Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 356
6
Diseases
7
Unique genes
0.260
Avg. similarity score
Colorectal cancer susceptibility
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Colorectal cancer susceptibility
POLD1-related polyposis and colorectal cancer syndrome
mandibular hypoplasia-deafness-progeroid syndrome
non-severe combined immunodeficiency due to polymerase delta deficiency
Paraquat lung disease
colorectal cancer, susceptibility to, 1
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Colorectal cancer susceptibility | 5 | 5 | 4 |
| POLD1-related polyposis and colorectal cancer syndrome | 3 | 3 | 1 |
| mandibular hypoplasia-deafness-progeroid syndrome | 3 | 3 | 1 |
| non-severe combined immunodeficiency due to polymerase delta deficiency | 3 | 3 | 2 |
| Paraquat lung disease | 1 | 1 | 3 |
| colorectal cancer, susceptibility to, 1 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| POLD1 | 4 / 6 | Colorectal cancer susceptibility, mandibular hypoplasia-deafness-progeroid syndrome, non-severe combined immunodeficiency due to polymerase delta deficiency, POLD1-related polyposis and colorectal cancer syndrome |
| GALNT12 | 2 / 6 | Colorectal cancer susceptibility, colorectal cancer, susceptibility to, 1 |
| SMAD7 | 2 / 6 | Colorectal cancer susceptibility, Paraquat lung disease |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| PCNA-Dependent Long Patch Base Excision Repair | Reactome | 3 / 21 | 245× | 1.61e-7 | 9.86e-6 ✓ sig. |
| Gap-filling DNA repair synthesis and ligation in GG-NER | Reactome | 3 / 25 | 206× | 2.77e-7 | 1.60e-5 ✓ sig. |
| Recognition of DNA damage by PCNA-containing replication complex | Reactome | 3 / 30 | 172× | 4.89e-7 | 2.63e-5 ✓ sig. |
| Termination of translesion DNA synthesis | Reactome | 3 / 32 | 161× | 5.97e-7 | 3.12e-5 ✓ sig. |
| DNA replication | KEGG | 3 / 36 | 143× | 8.59e-7 | 4.28e-5 ✓ sig. |
| Dual Incision in GG-NER | Reactome | 3 / 41 | 126× | 1.28e-6 | 6.06e-5 ✓ sig. |
| Base excision repair | KEGG | 3 / 44 | 117× | 1.59e-6 | 7.25e-5 ✓ sig. |
| HDR through Homologous Recombination (HRR) | Reactome | 3 / 48 | 107× | 2.07e-6 | 9.07e-5 ✓ sig. |
| Telomere C-strand (Lagging Strand) Synthesis | Reactome | 2 / 5 | 686× | 2.91e-6 | 1.21e-4 ✓ sig. |
| Nucleotide excision repair | KEGG | 3 / 63 | 81.7× | 4.74e-6 | 1.82e-4 ✓ sig. |
| Gap-filling DNA repair synthesis and ligation in TC-NER | Reactome | 3 / 65 | 79.2× | 5.21e-6 | 1.96e-4 ✓ sig. |
| Dual incision in TC-NER | Reactome | 3 / 66 | 78.0× | 5.46e-6 | 2.04e-4 ✓ sig. |
| Processive synthesis on the C-strand of the telomere | Reactome | 2 / 8 | 429× | 8.14e-6 | 2.82e-4 ✓ sig. |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | Reactome | 2 / 10 | 343× | 1.31e-5 | 4.19e-4 ✓ sig. |
| Processive synthesis on the lagging strand | Reactome | 2 / 10 | 343× | 1.31e-5 | 4.19e-4 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| DNA biosynthetic process | GO:0071897 | 3 / 32 | 250× | 1.59e-7 | 1.78e-5 ✓ sig. |
| DNA-templated DNA replication | GO:0006261 | 3 / 41 | 195× | 3.41e-7 | 3.38e-5 ✓ sig. |
| DNA replication proofreading | GO:0045004 | 2 / 3 | 1,780× | 3.61e-7 | 3.55e-5 ✓ sig. |
| nucleotide-excision repair, DNA gap filling | GO:0006297 | 2 / 6 | 890× | 1.80e-6 | 1.33e-4 ✓ sig. |
| base-excision repair, gap-filling | GO:0006287 | 2 / 14 | 381× | 1.09e-5 | 5.58e-4 ✓ sig. |
| DNA replication | GO:0006260 | 3 / 131 | 61.1× | 1.15e-5 | 5.82e-4 ✓ sig. |
| DNA synthesis involved in DNA repair | GO:0000731 | 2 / 23 | 232× | 3.03e-5 | 1.23e-3 ✓ sig. |
| negative regulation of cell differentiation | GO:0045596 | 2 / 75 | 71.2× | 3.29e-4 | 7.16e-3 ✓ sig. |
| negative regulation of BMP signaling pathway | GO:0030514 | 2 / 75 | 71.2× | 3.29e-4 | 7.16e-3 ✓ sig. |
| DNA repair | GO:0006281 | 3 / 420 | 19.1× | 3.69e-4 | 7.73e-3 ✓ sig. |
| positive regulation of chondrocyte hypertrophy | GO:1903043 | 1 / 1 | 2,670× | 3.75e-4 | 7.81e-3 ✓ sig. |
| beta-catenin destruction complex disassembly | GO:1904886 | 1 / 1 | 2,670× | 3.75e-4 | 7.81e-3 ✓ sig. |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 2 / 112 | 47.7× | 7.33e-4 | 1.24e-2 ✓ sig. |
| negative regulation of T-helper 17 type immune response | GO:2000317 | 1 / 2 | 1,335× | 7.49e-4 | 1.25e-2 ✓ sig. |
| DNA damage response | GO:0006974 | 3 / 577 | 13.9× | 9.34e-4 | 1.45e-2 ✓ sig. |